Stay informed with the latest litigation news. Explore now

IP Verse

Medimmune competitive analysis

Latest publications and patents of Medimmune New

Explore the latest publications and patents granted to Medimmune, showcasing their recent innovations and technological advancements.

Last updated on: Sep 9, 2025

Publication Number	Publication Date	Title	Legal Status
Get instant update for new patents of Medimmune
EP3218406	Oct 2, 2024	Binding Molecules Specific For Cd73 And Uses Thereof	Patent Maintained As Amended
EP3157629	Oct 5, 2022	Methods Of Cancer Treatment With Antagonists Against Pd-1 And Pd-L1 In Combination With Radiation Therapy	Granted And Under Opposition
EP1942939	Jul 7, 2021	Interleukin-13 Antibody Composition	Patent Maintained As Amended
EP3329018	Mar 31, 2021	Methods For Treating Hepcidin-Mediated Disorders	Revoked
EP2997036	Mar 3, 2021	Purification Of Recombinantly Produced Polypeptides	Granted And Under Opposition
EP2935268	Feb 17, 2021	Pyrrolobenzodiazepines And Conjugates Thereof	Patent Maintained As Amended
EP3072525	Jan 31, 2018	Methods Of Reducing Basophil Levels	No Opposition Filed Within Time Limit
EP2718320	Jan 10, 2018	Anti-Pseudomonas Psl Binding Molecules And Uses Thereof	No Opposition Filed Within Time Limit
EP2624859	Mar 1, 2017	Factor Ii And Fibrinogen For Treatment Of Haemostatic Disorders	Revoked

Latest patents of Medimmune opposed by its competitors

Explore Medimmune's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Sep 11, 2025

Patent Number	Grant Date	Title	Total Oppositions
EP3218406	Oct 2, 2024	Binding Molecules Specific For Cd73 And Uses Thereof	2
EP3157629	Oct 5, 2022	Methods Of Cancer Treatment With Antagonists Against Pd-1 And Pd-L1 In Combination With Radiation Therapy	1
EP1942939	Jul 7, 2021	Interleukin-13 Antibody Composition	1
EP3329018	Mar 31, 2021	Methods For Treating Hepcidin-Mediated Disorders	1
EP2997036	Mar 3, 2021	Purification Of Recombinantly Produced Polypeptides	2
EP2935268	Feb 17, 2021	Pyrrolobenzodiazepines And Conjugates Thereof	1
EP2624859	Mar 1, 2017	Factor Ii And Fibrinogen For Treatment Of Haemostatic Disorders	1

Latest PTAB cases involving Medimmune New

Discover the latest PTAB cases involving Medimmune, highlighting their recent legal challenges and patent disputes.

Top competitors of Medimmune

Top competitors of Medimmune based on patent oppositions.

GLAXOSMITHKLINE

OETKE

STRAWMAN